PTPN1 and neurodegenerative disease: Hence, the anti-inflammatory effects resulting from PTP1B inhibition could potentially have a protective role in neurodegenerative diseases by suppressing microglial hyperactivation and the consequent recruitment of immune cells to the brain [87,88,89].